Julie M Vose, MD
University of Nebraska · Nebraska Medical Center, Omaha, NE, USA
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julie M Vose, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:43 UTC. Open this list on ClinicalTrials.gov
- N/ANCT02553447 · Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D DeficiencyUniversity of Nebraska · completed · Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Untreated Chronic Lymphocytic Leukemia · principal investigator
- Ph2NCT01431209 · Ruxolitinib Phosphate to Treat Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin Lymphoma After Stem Cell TransplantUniversity of Nebraska · completed · Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma · principal investigator
- N/ANCT01142674 · T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell LymphomaAssociazione Angela Serra per la ricerca sul cancro · completed · Lymphoma, T-Cell, Peripheral · study chair
- Early Ph1NCT00736450 · Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell LymphomaUniversity of Nebraska · terminated · Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma · principal investigator
- N/ANCT00574626 · Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · principal investigator
- Ph1NCT00574509 · Hematopoietic Stem Cell Transplant for Recurrent Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · principal investigator
- Ph1/Ph2NCT00571493 · VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell LymphomaUniversity of Nebraska · completed · Non-hodgkin's Lymphoma, Mantle Cell Lymphoma · study chair
- Ph1/Ph2NCT00572013 · Rituxan and BEAM With Autologous Peripheral Blood Progenitor Transplant for Indolent LymphomaUniversity of Nebraska · completed · Lymphoma · principal investigator
- Ph1NCT00243087 · Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)Boehringer Ingelheim · completed · Lymphoma · study chair
- Ph2NCT00004197 · Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
- Ph2NCT00004192 · Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma, Neutropenia · study chair
- Ph3NCT00004112 · Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
- Ph2NCT00004198 · Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
- Ph2NCT00007852 · Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · principal investigator
- Ph3NCT00004874 · Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaUniversity of Nebraska · terminated · Lymphoma · study chair
- Ph2NCT00069966 · Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First RelapseTheradex · unknown · Lymphoma · study chair
- Ph1/Ph2NCT00031642 · Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell TransplantationUniversity of Nebraska · completed · Lymphoma · study chair
- Ph2NCT00007865 · Combination Chemotherapy Plus Rituximab in Treating Patients With Recurrent or Refractory Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
- Ph2NCT00006478 · Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's LymphomaUniversity of Nebraska · terminated · Lymphoma · study chair
- Ph2NCT00006695 · Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's LymphomaUniversity of Nebraska · completed · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Buffett Cancer Center Support GrantP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · fiscal years 1985 to 2026
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.